A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
NCT01268566
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DRUG:
MEDI-575
Sponsor
MedImmune LLC